EGFR and neoplasm: PDX models derived from fresh human tumor tissue have been widely used in the fields of oncological and pharmacological therapeutics as an effective study tool for translational medicine.18 We hence utilized these models to evaluate DTLL efficacy based on EGFR and HER‐2 expression levels that were obtained from RNA sequencing datasets available.